Quality of life in patients with psoriasis.

Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29

Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis (2012) 1.63

The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes (2009) 1.52

Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women. Br J Dermatol (2015) 1.40

Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med (2007) 1.20

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12

Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool. J Invest Dermatol (2011) 0.98

Impact of Psoriasis on Quality of Life: Relationship between Clinical Response to Therapy and Change in Health-related Quality of Life. Ann Dermatol (2010) 0.97

A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values. Patient Relat Outcome Meas (2015) 0.85

Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. Eur J Health Econ (2016) 0.85

A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis. Indian J Psychol Med (2015) 0.83

General measures and quality of life issues in psoriasis. Indian Dermatol Online J (2016) 0.80

Quality of life and psychosocial aspects in Greek patients with psoriasis: a cross-sectional study. An Bras Dermatol (2015) 0.79

Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory. Br J Dermatol (2014) 0.79

Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. J Am Acad Dermatol (2014) 0.79

An Applicator Delivery System for Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Topical Suspension (Gel): Innovating Psoriasis Vulgaris Treatment Through Patient Collaboration. Dermatol Ther (Heidelb) (2015) 0.78

Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Health Qual Life Outcomes (2012) 0.78

Microparticulate based topical delivery system of clobetasol propionate. AAPS PharmSciTech (2011) 0.78

Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence (2016) 0.78

[Psoriasis und Psoriasis arthritis in childhood and adolescence. Overview and consensus statement of the 9th Wörlitz Expert Round Table Discussion 2006 for the Society for Child and Adolescent Rheumatology]. Z Rheumatol (2007) 0.76

Psychopathological Variables and Sleep Quality in Psoriatic Patients. Int J Mol Sci (2016) 0.75

Influence of Psoriasis on Household Chores and Time Spent on Skin Care at Home: A Questionnaire Study. Dermatol Ther (Heidelb) (2015) 0.75

Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan. Prim Care Companion CNS Disord (2015) 0.75

Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms. Int J Behav Med (2016) 0.75

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol (2001) 3.92

Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol (1999) 3.60

Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40

Psoriasis. Lancet (2003) 3.05

The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol (2002) 2.40

Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol (2005) 2.19

Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med (2003) 2.12

The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol (2000) 2.10

Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol (2004) 1.94

Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol (2002) 1.85

The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol (1995) 1.73

The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol (2001) 1.53

The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol (2004) 1.53

Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol (2002) 1.37

Suicidal ideation in psoriasis. Int J Dermatol (1993) 1.37

Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin (2005) 1.36

Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med (1985) 1.33

An Italian study on psoriasis and depression. Dermatology (2006) 1.31

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol (1997) 1.30

Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol (2002) 1.21

Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol (2003) 1.17

Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol (1997) 1.11

The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol (2000) 1.10

Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol (2001) 1.10

Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol (1993) 1.10

Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol (2005) 1.06

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol (2005) 1.03

The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol (1997) 1.03

The negative impact of psoriasis on the workplace. J Dermatolog Treat (2006) 1.03

Quality of life issues in psoriasis. J Am Acad Dermatol (2003) 1.02

The impact of psoriasis on quality of life. Br J Dermatol (2001) 0.99

Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol (2005) 0.96

Psoriasis: current perspectives with an emphasis on treatment. Am J Med (1999) 0.93

The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res (2002) 0.93

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Br J Dermatol (2005) 0.89

Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost. Expert Opin Pharmacother (2003) 0.88

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]. BMC Dermatol (2005) 0.88

Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol (2000) 0.86

Group therapy: a useful and supportive treatment for psoriasis patients. Int J Dermatol (1997) 0.84

The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. J Cutan Med Surg (2005) 0.83

[Stigmatization and quality of life of patients with psoriasis and atopic dermatitis]. Hautarzt (2003) 0.83

Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res (2004) 0.81

The effect of treatment on quality of life in psoriasis patients. Acta Derm Venereol (2005) 0.79

Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate. Dermatology (2005) 0.79

A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis. Br J Dermatol (1998) 0.79

Current treatment options in psoriasis. Hosp Pract (1995) (2000) 0.77

Future psoriasis therapy. Dermatol Clin (1995) 0.77

Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol (2010) 8.55

Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet (2005) 8.23

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol (2008) 3.95

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88

Measuring patients' trust in their primary care providers. Med Care Res Rev (2002) 3.43

Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40

Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol (2003) 3.22

Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04

Production of complex nucleic acid libraries using highly parallel in situ oligonucleotide synthesis. Nat Methods (2004) 3.01

Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol (2009) 2.91

In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol (2002) 2.75

Trust in the medical profession: conceptual and measurement issues. Health Serv Res (2002) 2.46

The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol (2005) 2.26

Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol (2009) 2.14

Willing to wait?: the influence of patient wait time on satisfaction with primary care. BMC Health Serv Res (2007) 2.10

Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet (2012) 2.09

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol (2004) 2.05

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol (2011) 2.03

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol (2008) 1.99

Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol (2004) 1.94

Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol (2009) 1.94

Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol (2007) 1.76

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol (2009) 1.76

The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68

Switching from prescription to over-the counter medications: a consumer and managed care perspective. Manag Care Interface (2007) 1.67

The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care (2005) 1.64

Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat (2006) 1.64

Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther (2004) 1.62

Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complement Altern Med (2004) 1.60

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol (2006) 1.59

Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther (2007) 1.58

Drug samples in dermatology: special considerations and recommendations for the future. J Am Acad Dermatol (2010) 1.55

Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol (2010) 1.53

Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause (2010) 1.52

Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. Pediatr Crit Care Med (2009) 1.52

Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol (2008) 1.52

Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol (2007) 1.51

A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol (2010) 1.50

Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol (2007) 1.50

Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol (2012) 1.49

UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol (2008) 1.48

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol (2009) 1.48

Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol (2004) 1.45

Members of the national psoriasis foundation: more extensive disease and better informed about treatment options. Arch Dermatol (2005) 1.45

Economic evaluation of carotid artery stenting versus carotid endarterectomy for the treatment of carotid artery stenosis. J Am Coll Surg (2007) 1.44

Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol (2011) 1.44

Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol (2006) 1.44

Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs (2004) 1.43

Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol (2003) 1.43

Dermatosis neglecta: a series of case reports and review of other dirty-appearing dermatoses. Dermatol Online J (2006) 1.42

Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg (2015) 1.42

Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol (2005) 1.42

Percutaneous transluminal renal stenting for transplant renal artery stenosis. Catheter Cardiovasc Interv (2011) 1.41

How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat (2006) 1.40

Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol (2006) 1.40

Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol (2006) 1.40

Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). J Med Internet Res (2011) 1.39

Where did current academic dermatologists train? J Am Acad Dermatol (2010) 1.39

Increase in procedures performed at dermatology office visits from 1995 to 2001. Dermatol Surg (2005) 1.39

Phototherapy trends in dermatology. J Dermatolog Treat (2013) 1.38

US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37

Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics (2009) 1.35

Use of electronic medical records differs by specialty and office settings. J Am Med Inform Assoc (2013) 1.34

Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol (2007) 1.34

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol (2005) 1.34

Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol (2008) 1.28

Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc (2006) 1.27

Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis (2002) 1.27

The safety of liposuction: results of a national survey. Dermatol Surg (2002) 1.25

Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics (2009) 1.24

Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22

Patient injuries from surgical procedures performed in medical offices: three years of Florida data. Dermatol Surg (2004) 1.20

The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw (2010) 1.20

Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol (2011) 1.19

The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence (2012) 1.19

Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache (2003) 1.19

Tanning as an addictive behavior: a literature review. Photodermatol Photoimmunol Photomed (2009) 1.19

Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol (2007) 1.19

Correlates of patient satisfaction with physician visit: differences between elderly and non-elderly survey respondents. Health Qual Life Outcomes (2007) 1.18

Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol (2004) 1.17

What specialties perform the most common outpatient cosmetic procedures in the United States? Dermatol Surg (2007) 1.17

Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol (2005) 1.16

Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol (2004) 1.16

Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol (2014) 1.15

The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat (2005) 1.14

Stress and adaptation in mothers of children with cerebral palsy. J Pediatr Psychol (2003) 1.13

A review of targeted ultraviolet B phototherapy for psoriasis. J Am Acad Dermatol (2011) 1.12